Literature DB >> 24556550

Evaluation of vancomycin dosing protocols to achieve therapeutic serum concentrations in patients receiving high-flux haemodialysis.

Shang-Yi Lin1, Mei-Chiou Shen2, Shang-Jyh Hwang3, Yen-Hsu Chen3, Tun-Chieh Chen4, Yee-Wen Chiu3, Po-Liang Lu5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24556550     DOI： 10.1016/j.ijantimicag.2014.01.002

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  7 in total

Review 1.  Optimizing the Clinical Use of Vancomycin.

Authors:  Rocío Álvarez; Luis E López Cortés; José Molina; José M Cisneros; Jerónimo Pachón
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

2.  Predicting Maintenance Doses of Vancomycin for Hospitalized Patients Undergoing Hemodialysis.

Authors:  Wasim S El Nekidy; Maher M El-Masri; Greg S Umstead; Michelle Dehoorne-Smith
Journal:  Can J Hosp Pharm       Date:  2016-10-31

3.  Validation of a Weight Threshold-Based Vancomycin Dosing Protocol for Patients Undergoing Intermittent Hemodialysis.

Authors:  Lu Xuan Lisa Sun; Kang-Wei David Liu; Stephanie Lynch; Mielen Mistry; Heather Wise; Eduard Iliescu
Journal:  Can J Hosp Pharm       Date:  2019-10-21

4.  The ratio of pre-dialysis vancomycin trough serum concentration to minimum inhibitory concentration is associated with treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Chien-Fang Fu; Jiun-Da Huang; Jann-Tay Wang; Shu-Wen Lin; Chien-Chih Wu
Journal:  PLoS One       Date:  2018-03-05       Impact factor: 3.240

5.  Pharmacokinetics of Vancomycin in Pediatric Patients Receiving Intermittent Hemodialysis or Hemodiafiltration.

Authors:  Erin Chung; James A Tjon; Rosaleen M Nemec; Nadya Nalli; Elizabeth A Harvey; Christoph Licht; Winnie Seto
Journal:  Kidney Int Rep       Date:  2021-02-06

6.  Association of bacterial genotypes and epidemiological features with treatment failure in hemodialysis patients with methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Shang-Yi Lin; Hung-Pin Tu; Tun-Chieh Chen; Mei-Chiou Shen; Yi-Wen Chiu; Yen-Hsu Chen; Po-Liang Lu
Journal:  PLoS One       Date:  2018-06-04       Impact factor: 3.240

7.  Evaluation of Factors which Influence Mortality in Gram-positive Bacteremia in Hemodialysis Patients.

Authors:  Kerry Anne Rambaran; Saeed K Alzghari; Charles F Seifert
Journal:  Cureus       Date:  2018-07-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.